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Gastro-oesophageal reflux occurs for 3% of the measured
time in normal people, but does not produce oesophagitis
because of an effective acid-clearing mechanism and a
mucosal resistance to hydrogen ions. A mechanically
defective lower oesophageal sphincter is the primary
disorder responsible for abnormal reflux, but poor acid-
clearing resulting from defective motility, a high acid
output, bile contamination of refluxing gastric content
and delayed gastric emptying may contribute to the
severity of the damage caused.
The potential for reflux is linearly related to lower
oesophageal sphincter pressure. l Recently, Dent et aJ.2
have shown that lower oesophageal sphincter relaxation,
which occurs independently of swallow responses, is the
commonest defect in the lower oesophageal sphincter
mechanism in abnormal reflux. They suggest that this
abnormality is related to a neural defect in the oeso-
phagus. There is also evidence to support the concept
that there is a progressive deterioration of oesophageal
muscle power with increasing severity of reflux. 3 In
particular, lower oesophageal sphincter pressure and the
height of contraction responses in the body of the
oesophagus are markedly decreased in advanced reflux
disease with stricture or Barrett's syndrome (columnar-
lined epithelium in the oesophagus). Non-propagating
contraction responses to swallowing are more prevalent
in advanced disease, again suggesting that reflux has
caused neural damage to the intrinsic oesophageal nerve
plexuses. We have confirmed this finding in an analysis
of motility responses to swallowing in the columnar-
lined oesophagus, which is considered to be end-stage
reflux disease.
Ogilvie et al. 4 have demonstrated that although vagal
impairment is common in reflux oesophagitis, it is not
confined to the alimentary tract, suggesting that it is not
reflux-induced but that it may be important in the
pathogenesis of reflux oesophagitis. Transmural fibrosis
has been found in resected specimens from such patients.3
Clinically, such abnormalities are associated with a
variety of symptoms such as heartburn, dysphagia, chest
pain, haemorrhage, acid laryngitis, vocal cord polyps
and 'gastric asthma'. Reflux in infants may interfere
with· feeds and result in failure to thrive. The Sandifer
syndrome in children is caused by gastro-oesophageal
reflux, and presents with dystonic movements of the
head and neck. Life-threatening aspiration and bronchial
asthma can be associated with inhalation in infants with
gastro-oesophageal reflux.
Conservative therapy has been the predominant treat-
ment for the majority of patients presenting with reflux
oesophagitis, and consists of weight control, postural
treatment and antacids. With the advent of the H2-
receptor blocking drugs and prokinetic agents, responses
to medical treatment have been infinitely better. More
recently, omeprazole therapy has given remarkable
results.
We now need to consider how effective medical therapy
is in the management of gastro-oesophageal reflux. In
one study on infants and children,S postural therapy
together with antacids, bethanechol and cimetidine was
effective by 18 months of age in 80% of patients, but
surgery was necessary in 17% of children in the series.
The remarkable results of issen fundoplication in
children, and particularly in retarded children, have
been reported by numerous authors in recent years.
Fonkalsrud et al.6 reported excellent results with low
morbidity and mortality in 270 children, illustrating
how frequently the operation is now performed in
paediatric practice. Definite indications for surgery in
infants and children with gastro-oesophageal reflux
therefore include a failure to thrive, respiratory compli-
cations and failure to respond to medical treatment. The
period of trial of medical therapy must be individualised
according to the clinician's evaluation, but if this is too
prolonged it could be detrimental to the patient and to
oesophageal function. Similarly, not all adult patients
respond to medical therapy.
Behar et al. 7 identified a group of patients with reflux
oesophagitis who did not respond well to medical therapy
- those with an incompetent lower sphincter, free-acid
reflux and severe oesophagitis. More recently Lieberman
and Keeffe8 independently reported on poor results of
intensive medical therapy, which included the use of
H 2-receptor blockers· and prokinetics in a group of
patients with poor lower oesophageal sphincter pressure.
Surgery was eventually necessary in 8% of their cases.
The above two reports from physician gastro-entero-
logists have been the first attempts to look at the
problem realistically without condemning all categories
of patients to medical therapy only, which is ineffective
in a small number of cases. Mucosal protection with
sucralfate has given results equal to those reported with
the use of cimetidine,9 and may have an added benefit in
patients with alkaline reflux. Newer and more powerful
acid blockers and prokinetics are being evaluated, and a
combination of omeprazole and· cisapride will surely
give even better results. But these patients will be drug-
dependent at great cost, and possible detriment to health.
Furthermore, as yet there is no proof that the progressive
deterioration in oesophageal function associated with
reflux will be prevented by these drugs. The motility
defects in the oesophagus are irreversible, even after
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surgical therapy. Should these defects be allowed to
progress to such a state of irreversibility?
In our experience, prokinetic drugs have the least
effect where needed most, viz. poor lower oesophageal
sphincter pressures and impaired oesophageal function. 10
The reason for failed medical therapy may be related to
poor motility, resulting in inadequate acid clearance,
and 'alkaline' reflux. There is no satisfactory medical
treatment for 'alkaline' reflux, and bile-diverting pro-
.cedures have often been the only solution for intractable
reflux complications. The operation of antrectomy,
vagotomy and Roux-en-Y diversion produces excellent
results in 80-85% of cases, I I and the newer 'duodenal
switch' operation 12 (suprapapillary duodenojejunal
anastomosis) may give superior results because the
pylorus and vagus nerves are spared.
Advances in surgical technique are thus taking place
concurrently with the introduction of newer and better
drug therapy. These operations are aimed at restoring a
mechanically defective lower sphincter, decreasing acid
output or deviating irritant duodenal secretions. In
extreme cases, oesophageal replacement is necessary,
particularly in reflux strictures that have not responded
to dilatation and medical therapy.
All clinicians will agree that the best treatment for
other mechanical defects, such as inguinal hernia and
rectal prolapse, is surgical. With a very low morbidity
and mortality rate, a simple anti-reflux operation will
give a success rate of 91%over 10 years13 and is surely in
the same category?
A stitch in time may prevent neural damage from
long-continued reflux, and in many cases must be the
correct therapy for serious reflux oesophagitis. The dis-
comfort of wearing a truss for a hernia may be compared
with the restricted living on medical therapy for serious
reflux. The persistent use of conservative measures by
some clinicians is very distressing to many patients, and
the question should be asked whether it is ethical to
withhold a better alternative in these selected cases.
Repeated endoscopies we have performed over a 6-
year period in 18 patients with a columnar-lined oeso-
phagus, treated vigorously with H 2-receptor blockers
and prokinetics, have shown a progression of the
columnar segment in 14 patients. This is evidence that
reflux has not been adequately controlled on these
medical measures. The H2-receptor blOckers have not
given satisfactory results in all patients when used in a
regular dosage schedule, and double-dosage regimens
have now been recommended. From reported results of
the medical management of reflux oesophagitis, it is
obvious that not all patients will benefit adequately from
such therapy and that surgery in these cases gives
predictably good results. In many instances the failure
of surgery has been the result of inadequate assessment
of the physiological defect or poor technical surgery,
and such operations by inexperienced surgeons will not
equal the expected good results. Whether long-continued
medical therapy will prevent deterioration of oesophageal
function or not remains to be tested. Repeated physio-
logical tests of oesophageal function over long periods of
time will be necessary to answer this question.
The definite indications for surgery in adult patients
therefore are a failure of medical therapy and pulmonary
complications of reflux. It is our conviction that reflux
strictures of the oesophagus and the columnar-lined
oesophagus are further definite indications 14-16 for
surgery, but such complications are frequently treated
world-wide by medical measures, which include drug
dependence, frequent consultations and a more restricted
lifestyle than that offered by successful surgery. That
there is no permanent cure by medical therapy is a fact
infrequently explained to the patient, and compliance
with long-continued drug taking, particularly from
younger and middle-aged patients, is an unusual event.
Yes, there are defmite indications for the surgical
correction of gastro-oesophageal reflux. However, before
surgery is undertaken, appropriate investigations to
elucidate the pathophysiology of the defect are manda-
tory. Corrective surgery can then be planned to give
optimal and long-lasting results.
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